FGF23 and hypophosphatemia: Therefore, the increase in FGF23 produces phosphate wasting and inappropriately low-circulating 1,25(OH)2D3 levels, including secondary hypophosphatemia and hypocalcemia, ectopic calcifications and impaired bone mineralization.